Speech by Chancellor Scholz on the occasion of the opening of the World Health Summit 2022 on October 16, 2022, in Berlin

Germany Olaf Scholz · Member of the Bundestag

16 October 2022 · World Health Summit 2022 · Berlin, Germany

Context
Scholz addressed the World Health Summit 2022 opening in Berlin on October 16, delivering remarks on global health cooperation and pandemic preparedness.
Main themes
Global health cooperation, basic research importance, One Health approach, pandemic preparedness, mRNA technology, paleogenetics, scientific networking, research funding, COVID-19 lessons, interdisciplinary collaboration
Duration
~13 min
47th percentile
Words
1,617
47th percentile
Sentences
87
56th percentile
Readability
41
38th percentile
Grade
12.0
46th percentile
Syntax
2.82
24th percentile
Vocabulary
2.40
90th percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 40%40%
  • Ceremonial 26%26%
  • Institutional 14%14%
  • Economic 11%11%
  • Geopolitical 6%6%
  • Technological 1%1%
  • Environmental 1%1%
  • Not in focus 0%

87 sentences in 38 paragraphs

Dear Director-General Tedros,

dear Professor Pries,

dear Dr. Boehme,

dear participants of the World Health Summit,

ladies and gentlemen,

a few days ago, the Nobel Committee in Stockholm announced this year's laureate of the Nobel Prize in Medicine. Many of you know him, of course: it is Professor Svante Pääbo.

I was particularly pleased with this choice. On the one hand, of course ‑ this is obvious ‑ because Professor Pääbo has been teaching and researching here in Germany since the 1990s ‑ first at the University of Munich, later at the Max Planck Institute for Evolutionary Anthropology in Leipzig. This makes us proud; it speaks for the research location Germany. On the other hand, I was pleased because we are sometimes somewhat ridiculed internationally for supposedly conducting too much basic research here in Germany.

I keep hearing about the dilemma between pressure for results and innovation that many scientists, especially in basic research, face, and the difficulty of securing third-party funding. But now they can refer to the Nobel Prize winner.

Even as a student of Egyptology and medicine, he began researching the bones of Egyptian mummies - secretly and always worried that his doctoral supervisor and the scientific community would think he was crazy. By the way, he got his first research material from the Egyptian Museum in what was then East Berlin. That was in 1984.

The doctoral student actually succeeded in finding DNA in the cells of a mummified child. But as it sometimes happens: this scientific breakthrough was initially published in a rather obscure journal in the former GDR. Until some researchers from Berkeley took notice. The rest is history.

A year later, the publication "Molecular cloning of Ancient Egyptian mummy DNA" was the cover story in Nature Magazine. International newspapers enthusiastically reported on the findings. A new medical discipline was born: paleogenetics.

In the meantime, the Nobel laureate and his colleagues have not only found answers to how much of our genetic material we, or at least some of us as Homo sapiens, share with our predecessor, the Neanderthal. I will say quite unscientifically: it is between 1 and 2 percent. These gene variants, however, still influence how our bodies respond to certain diseases today. Thanks to the professor's studies, we know, for example, that some of us - from this time of interaction with the Neanderthal - carry a variant on chromosome 3 that significantly increases the risk of severe illness from Covid-19.

Ladies and gentlemen, I believe we can learn a lot from this story.

First: Basic research matters.

That Professor Christian Drosten, who is the director of the Institute of Virology here at Charité, developed a first successful virus detection just a few weeks after the appearance of the coronavirus in Wuhan was also the result of years of research on coronaviruses - at a time when these viruses were unknown to most citizens.

And that Uğur Şahin and Özlem Türeci were able to produce a successful vaccine against Covid-19 in their company BioNTech in a very short time is also due to years of research on mRNA technologies. This has saved countless lives during the Covid-19 pandemic. And I hope this is just the beginning ‑ just think of the potential of mRNA technology in cancer therapy.

As the federal government, we will therefore continue to vigorously promote free, curiosity-driven research. This is what the Pact for Research and Innovation stands for. This also represents our commitment to further increase funding for research and development ‑ to 3.5 percent of gross domestic product by the year 2025.

Ladies and gentlemen, however, the example of Professor Pääbo shows something else: Networking matters, collaboration matters ‑ and across national borders, between different scientific disciplines, and also between science, politics, and society. Without the attentive colleagues from Berkeley, his groundbreaking research on the DNA of our ancestors might have ended up in some drawer.

The World Health Summit also stands for networking and collaboration. In the coming days, you will engage in intensive discussions here ‑ internationally, interdisciplinary, and at the highest scientific level. The significance of this ‑ the Covid-19 pandemic has made this clear to us. Like other epidemics of recent years, it was likely caused by pathogens that were transmitted from animals to humans.

If we want to recognize such epidemics earlier in the future or ‑ better yet ‑ avoid them, we need much closer collaboration between different disciplines, a much better understanding of the connections between the health of humans, animals, and the environment. One Health is the key term.

This is, of course, just one of many areas where complexity is increasing in a world that is becoming more interconnected, increasingly shaped by scientific innovations and technological progress. All the more, politics today relies on the advice of science.

Right at the beginning of my term as Chancellor, I therefore appointed an independent council of Covid-19 experts. Since then, 19 scientists have been accompanying and advising us in the fight against the pandemic. Some of them are also here today.

In twelve statements so far, they have provided us with valuable insights ‑ in health policy, but also, for example, regarding our communication. Just as science continually expands its knowledge, formulates new hypotheses, and tests them, so too must science-based policy continually review and adjust its course.

Even in international comparison, it can be observed today: Those who have done this, who have listened to the advice of experts, have fared better through this pandemic than those who rigidly and ideologically adhered to a specific crisis management strategy. This success should strengthen us in one thing: to clearly confront those who deliberately question scientific progress, who spread targeted disinformation, and who even defame and threaten scientists.

To be clear: We cannot and will not accept threats against scientists. Academic freedom is a precious good, and together we will defend it! Transparency is important for this ‑ transparency, as we have established through the publication of the advice from our Covid-19 experts. This not only strengthens trust in scientific and political decisions ‑ it also helps to counter some disinformation campaigns.

And I am grateful for the contribution that the World Health Summit and all of you make by making scientific information accessible to citizens ‑ even beyond professional circles.

Ladies and gentlemen, networking and collaboration matter ‑ this also applies internationally, especially in the field of international health policy. As the G7 presidency, we have therefore made health a focus of our agenda. The G7 partners have now delivered almost 1.2 billion vaccine doses ‑ more than initially promised.

The ACT-Accelerator, which makes vaccines, therapeutics, and diagnostics quickly available worldwide, is 83 percent funded by the G7. Germany alone pledged over 1.3 billion euros for this in 2022.

With up to 850 million euros, we support countries in Africa and the Middle East to ensure that donated vaccines are actually administered. And together with the EU, the African Union, and African countries like Senegal and Rwanda, we support the establishment of local vaccine production in Africa ‑ today with a view to Covid-19, tomorrow also against other diseases like malaria or Ebola.

By the way: It is important that you keep the fight against exactly these diseases in focus here at the World Health Summit, alongside the Covid-19 pandemic. Millions of people in Asia, Africa, and Latin America are affected by tropical diseases that continue to be overlooked. We want to change that. With 1.3 billion euros, we are therefore supporting the Global Fund to Fight AIDS, Tuberculosis, and Malaria ‑ an increase of 30 percent since the last replenishment of the fund.

And polio finally belongs in the medical historical museum. Therefore, Germany will provide 35 million euros at the Global Polio Eradication Initiative conference next Tuesday for a world without polio this year.

Ladies and gentlemen, with that, I have arrived in the future. And this future benefits from our ability to draw the right conclusions from the past ‑ this is also a possible lesson from paleogenetics.

In this spirit, I would like to make an appeal to all of us: Let us draw the right conclusions from the Covid-19 pandemic together! Preparedness matters!

The global community must be better prepared for future pandemics, must recognize threats more quickly, exchange information more closely, develop countermeasures together, and ensure access for all. Under our G7 presidency, we have therefore agreed on a Pact for Pandemic Readiness. This includes, for example, closer collaboration in genome sequencing or monitoring wastewater systems to detect outbreaks earlier. In New York, for example, a polio outbreak was detected early in September, and a disaster declaration was issued accordingly.

In September, we established a "Financial Intermediary Fund" to financially secure preparedness and response to pandemics. Germany has so far provided almost 70 million euros for this ‑ as one of now 18 donors from all parts of the world.

And finally, we support negotiations on an international pandemic treaty and amendments to the International Health Regulations to be better prepared together and to act more effectively in health crises.

Ladies and gentlemen, drawing the right conclusions from the past for the future ‑ this is a quality that Homo sapiens has over its predecessors. Why ‑ this question Professor Pääbo could probably answer very quickly from a paleogenetic perspective. Looking at this room, my answer is: because we have great scientists with a research gene, because we network and collaborate, and because we are willing to think beyond the day ‑ regardless of how much Neanderthal genetic material we still carry within us.

Welcome to Berlin! I wish you all a successful and insightful World Health Summit 2022!